Oral Drug

Revlimid proves effective for bone marrow cancer

According to new findings from the Rush University Medical Center, “unprecedented” survival for multiple myeloma patients was seen with an oral drug, Revlimid.
Multiple Myeloma is a form of blood cancer that happens in the blood making cells of bone marrow.
It was revealed in the findings that patients treated with the oral drug, Revlimid, had a [...]

July 20, 2009 | Posted in Steroids Blog | Read More »

Abiraterone minimizes levels of Prostate-specific Antigen

A new drug candidate, abiraterone, has been showing enough promise in initial trials for helping prostate cancer patients whose tumors have not stopped growing despite medical or surgical castration.
Abiraterone has proved to be an effective option for reducing the levels of prostate-specific antigen and tumors in prostate carcinoma patients who have undergone hormone therapy but [...]

July 17, 2009 | Posted in Steroids Blog | Read More »